‘Tripledemic’ demand for Motrin and Tylenol fueled year-end sales in J&J’s consumer business
January 24, 2023 at 13:05 PM EST
Johnson & Johnson cited Motrin and Tylenol as 'major contributors to growth' in its over-the-counter division
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|